GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Mar 27, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-transaction
Related Tickers: GSK
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on March 27, 2025, that it purchased a certain number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing does not specify the exact number of shares or the total dollar amount involved in these transactions.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of share repurchases and does not contain significant new risks.
Key Players & Entities
- GSK plc (company) — Registrant
- Citigroup Global Markets Limited (company) — Corporate stockbroker
- 31¼ pence (dollar_amount) — Nominal value of ordinary shares
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K filing is to report a transaction in GSK plc's own shares.
Who is acting as GSK's corporate stockbroker for these transactions?
Citigroup Global Markets Limited is acting as GSK's corporate stockbroker.
What type of shares did GSK purchase?
GSK purchased its own ordinary shares of 31¼ pence each.
On what date did the reported share purchase occur?
The filing indicates the date of purchase was in March 2025, with the specific date of purchase being March 27, 2025.
Does GSK file annual reports under Form 20-F or Form 40-F?
GSK indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 27, 2025 regarding GSK plc (GLAXF).